Abstract
Essential thrombocythemia (ET) is a clonal myeloproliferative disease that involves a multipotent stem cell common to the megakaryocyte, granulocytic, and erythrocytic lines (16). In ET the major abnormality is represented by the increase of the megakaryocyte number, volume, and mass (13,25,26,45). The resulting platelet production is usually 4–6 times more than the normal value, while the platelet survival is normal or slightly decreased (25,29,34,43,45).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.I. Barnhart, T.H. Kim, B.L. Evatt, A.H. Ragab, V.K. Lui, J. Herman, and J.M. Lusher, Essential thrombocythemia in a child: platelet ultrastrueture and function, Am. J. Hematol., 8: 87 (1980).
T.A. Bensinger, G.L. Logue, and R.W. Rundles, Hemorrhagic thrombocythemia: control of postsplenectomy thrombocytosis with melphanan, Blood, 36: 61 (1970).
G. Biagini, L. Gugliotta, P. Preda, A. Guarini, G. Fumagalli, and R. Laschi, Platelets in primary thrombocythemia: electron miscroscopic study, Nouv. Rev. Fr. Hematol., 24: 19 (1982).
R.B. Bolin, T. Okumura, and G.A. Jamieson, Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders, Am. J. Hematol., 3: 63 (1977).
B. Boneu, C. Nouvel, P. Sie, C. Caranobe, D. Combes, G. Laurent, G. Pris, and R. Bierme, Platelets in myeloproliferative disorders, I. A comparitive evaluation with certain platelet function tests, Scand. J. Haematol., 25: 214 (1980).
B.J. Boughton, W.E.N. Corbett, and A.D. Ginsburg, Myleo-proliferative disorders: a paradox of in vivo and in vitro platelet function, J. Clin. Path., 30: 228 (1977).
I. Brodsky, Effect of busulfan on oncornavirus-like activity in platelets and chromosomes in polycythaemia vera and essential thrombocythaemia, J. Natl. Canc. Inst., 59: 61 (1977).
C. Caranobe, P. Sie, C. Nouvel, G. Laurent, J. Pris, and B. Boneu, Platelets in myeloproliferative disorders, II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density, Scand. J. Haematol., 25: 289 (1980).
B. Cooper, A. Shafer, D. Puchalsky, and R. Handln, Platelet resistence to prostaglandin D2 in patients with myeloproliferative disorders, Blood, 52: 618 (1978).
S. Cortelazzo, M. Colucci, T. Barbui, E. Dini, and N. Semeraro, Reduced platelet factor X activating activity. A possible contribution to bleeding complications in polycythaemia vera and essential thrombocythaemia, Haemostasis, 10: 37 (1981).
W. Dameshek, Some speculations on the myeloproliferative syndromes, Blood, 6: 372 (1951).
N. Eche, P. Sie, C. Caranobe, C. Nouvel, J. Pris, and B. Boneu, Platelets in myeloproliferative disorders, III. Glyco-protein profile in relation to platelet function and platelet density, Scand. J. Haematol., 26: 123 (1981).
E. Epstein and A. Goedel, Hämorrhagische thrombocythämie bei vasculärer Schrumpfmilz, Virch. Arch., 293: 233 (1934).
M. Fickers and B. Speck, Thrombocythaemia, Acta Haematol., 51: 257 (1974).
P.G. Frick, Primary thrombocythemia, Helv. Med. Acta, 20: 344 (1969).
G.F. Gaetani, A.M. Ferraris, S. Galiano, P. Giuntini, L. Canepa, and M. D’Urso, Primary thrombocythemia: clonal origin of platelets, erythrocytes and granulocytes in AGdB/Gd Mediterranean subject, Blood, 59: 76 (1982).
D. Goldfinger, Long-term plateletpheresis in the management of primary thrombocytosis, Transfusion, 19: 336 (1979).
L. Gugliotta, A. Guarini, A. Zaccaria, and S. Tura, Platelet function in primary thrombocythemia and chronic myeloid leukemia, Proceedings XVII Congress of the International Society of Hematology, Paris (1978).
L. Gugliotta, A. Guarini, C. Timoncini, A. Modiano, M. Aieta, and S. Tura, Valutazione elettronica dei parametri volumetrici delle piastrine nella trombocitemia primitiva e nella porpora thrombocitopenica idiopatica, XXVIII Congresso Nazionale Società Italiana di Ematologia, Bari (1981).
L. Gugliotta, G. Cavazzini, M. Baccarani, S. Tura, and The Essential Thrombocythaemia Italian Study Group, The survival of patients with essential thrombocythaemia, (in preparation).
L. Gugliotta, G. Biagini, A. Guarini, and P. Preda, Platelet aggregation in essential thrombocythaemia: evaluation by electron microscopy (in preparation).
L. Gugliotta, C. Pickering, M. Greaves, and F.E. Preston, Abnormality of platelet membrane glycoproteins in essential thrombocythemia, Thromb. Haemost., 50: 216 (1983).
F.W. Gunz, Hemorrhagic thrombocythemia: a critical reveiw, Blood, 15: 706 (1960).
R.M. Hardisty and H.H. Wolff, Haemorrhagic thrombocythaemia: a clinical and laboratory study, Br. J. Haematol., 1: 390 (1955).
L.A. Harker and C.A. Finch, Thrombokinetics in man, J. Clin. Invest., 48: 963 (1969).
L.A. Harker, Thrombokinetics, in: “The Platelet,” K.M. Brinkhous, ed., Williams and Wilkins, Baltimore (1971).
S. Holme, M. Simmonds, R. Ballek, and S. Murphy, Comparative measurements of platelet size by Coulter Counter, microscopy of blood smears and light transmission studies. Relationship between platelet size and shape, J. Clin. Med., 97: 610 (1981).
P. Kaywin, M. McDonough, P. Insel, and S.J. Shattil, Platelet function in essential thrombocythaemia. Decreased epinephrine responsiveness associated with a deficiency of platelet α-adrenergic receptors, N. Engl. J. Med., 299: 505 (1978).
H. Lander and M.G. Davey, The behaviour and survival of platelets in polycythaemia and thrombocythaemia, Aust. Ann. Med., 13: 207 (1964).
J. Lazlo, Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary haematopoiesis, undifferentiated MPD, and haemorrhagic thrombocythaemia, Semin. Hematol., 12: 409 (1975).
S.M. Lewis, L. Szur, and A.V. Hoffbrand, Thrombocythemia, in: “Clinics in Haematology,” Vol. 1 (1972).
M.L. Mester, L. Szabados, P.R. Guinebault, J. Caen, and S. Levy-Toledano, Variations de l’acide sialique plaquettaire dans les thrombopathies constitutionelles et acquieses, C.R. Acad. Sci. Paris, 273: 2157 (1971).
S. Murphy, J.L. Davis, P.N. Walsh, and F.H. Gardner, Template bleeding time and clinical hemorrhage in myeloproliferative disease, Arch. Intern. Med., 138: 1251 (1978).
Y. Najean, Platelet life span, Ann. Rev. Med., 20: 47 (1969).
J. Nishimura, S. Okamoto, and H. Ibayashi, Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders, Thromb. Haemost., 41: 787 (1979).
M. Okuma and H. Uchino, Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders, Blood, 54: 1258 (1979).
F.I. Pareti, A. Capitanio, L. Mannucci, C. Ponticelli, and P.M. Mannucci, Acquired dysfunction due to the circulation of “exhausted” platelets, Am. J. Med., 69: 235 (1980).
F.I. Pareti, L. Gugliotta, L. Mannucci, A. Guarini, and P.M. Mannucci, Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders, Thromb. Haemost., 47: 84 (1982).
F.E. Preston, I.G. Emmanuel, D.A. Winfield, and R.G. Malia, Essential thrombocythaemia and peripheral gangrene, Br. J. Med., 3: 548 (1974).
N.H. Russel, J. Salmon, J.P. Keenan, and A.J. Bellingham, platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders, Thromb. Res., 22: 389 (1981).
A.I. Schafer, Deficiency of platelet lipoxygenase activity in myeloproliferative disorders, N. Engl. J. Med., 306: 381 (1982).
R.H. Spaet, I. Lejnieks, E. Gaynor, and M.L. Goldstein, Defective platelets in essential thrombocythemia, Arch. Intern. Med., 124: 135 (1969).
S. Tura, Le trombocitemie, Haematologica, 64(Suppl.): 179 (1979).
L.R. Vasserman, L. Vroman, and G. Gelin, Hémorragies et thromboses an cours de la thrombocythémie essentielle (a propos de 3 observations personelles), Sang, 29: 560 (1958).
A. Weinfeld, I. Branehog, and J. Kutti, Platelets in the myeloproliferative syndrome, Clin. Haematol., 4: 373 (1975).
M.M. Wintrob, “Clinical Hematology,” Lea and Febiger, Philadelphia (1981).
A. Zaccaria, M. Baccarani, L. Gugliotta, and S. Tura, 21 q: a candidate chromosome marker of primary thrombocythaemia, Haematologica, 63: 337 (1978).
S. Zucker and C.H. Mielke, Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications, J. Lab. Clin. Med., 80: 385 (1972).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Tura, S. et al. (1985). Clinical and Biological Aspects of Essential Thrombocythemia. In: Cajozzo, A., Perricone, R., Di Marco, P., Palazzolo, P. (eds) Advances in Hemostasis and Thrombosis. Ettore Majorana International Science Series, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9424-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9424-6_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9426-0
Online ISBN: 978-1-4615-9424-6
eBook Packages: Springer Book Archive